Primera experiencia en España de la modulación de la contractilidad cardiaca. Una nueva alternativa para los pacientes con insuficiencia cardiaca

Bagudá, Javier de Juan; Fontenla, Adolfo; García-Cosío Carmena, María Dolores; Salguero Bodes, Rafael; Delgado Jiménez, Juan F; Arribas Ynsaurriaga, Fernando.
Rev. esp. cardiol. (Ed. impr.) ; 73(10): 855-857, oct. 2020. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-199635

Documentos relacionados

  1. [Dilated cardiomyopathy: a toxic cause?]
  2. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
  3. Genetic Testing as a Guide for Treatment in Dilated Cardiomyopathies.
  4. Mechanical Circulatory Support Devices Among Patients With Familial Dilated Cardiomyopathy: Insights From the INTERMACS.
  5. Myocardial recovery in a patient with dilated cardiomyopathy after short-term biventricular assist device support.
  6. Genetics of Dilated Cardiomyopathy.
  7. Long term CentriMag biventricular support using hybrid cannulation as a bridge to transplant in a pediatric patient.
  8. Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support.
  9. Treatment Strategies for Dilated Cardiomyopathy in Children: Scientific Statement from the American Heart Association-A Real Advance! But Please More Specific!
  10. Proteomic Profiling of Dilated Cardiomyopathy Plasma Samples ─ Searching for Biomarkers with Potential to Predict the Outcome of Therapy.